Picture of Biohit Oyj logo

BIOBV — Biohit Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Biohit: Results Of Migraine Study To Be Delayed

Sept 7 (Reuters) - Biohit Oyj  BIOBV.HE :
    * RESULTS OF THE MIGRAINE STUDY WILL BE DELAYED FROM THE  PREVIOUSLY REPORTED SCHEDULE
    * DUE TO THESE CHALLENGES, FINAL RESULTS WILL NOT BE AVAILABLE UNTIL FIRST REPORTING PERIOD
OF
2019
    * SAYS IN ESTONIA, UNEXPECTED PROBLEMS HAVE BEEN ENCOUNTERED IN FINDING ELIGIBLE PATIENTS
FOR
STUDY

Source text for Eikon:  ID:nGNE6Ky6SH 
Further company coverage:  BIOBV.HE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Biohit Oyj

See all news